Time to add chemotherapy to radiotherapy for cervical cancer

Lancet

Volumn 353, Issue 9161, 1999, Pages 1288-1289

  Monaghan, J ^a  

^a QUEEN ELIZABETH HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CISPLATIN; FLUOROURACIL; HYDROXYUREA;

CANCER ADJUVANT THERAPY; CANCER CHEMOTHERAPY; CANCER INVASION; CANCER RADIOTHERAPY; CANCER SURVIVAL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; HEMATOLOGIC DISEASE; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MAJOR CLINICAL STUDY; NOTE; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; UTERINE CERVIX CANCER;

EID: 0033577507     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(99)00073-2     Document Type: Note

References (4)

1. PG Rose BN Bundy EB Watkins Concurrent cisplatin-based radiotherapy and chemotherapy for locally advanced cervical cancer N Engl J Med 340 1999 1144 1153
2. PJ Morris M Eifel J Lu Pelvic radiation with concurrent chemotherapy compared with pelvic and para-aortic radiation for high-risk cervjcal cancer N Engl J Med 340 1999 1137 1143
3. BN Keys HM Bundy FB Stehman Cisplatin, radiation, and adjuvant hsyterectomy compared with radiation and adjuvant hysterectomy for bulky stage 1b cervical carcinoma N Engl J Med 340 1999 1154 1161
4. Grogan M, Thomas GM, Melamed I, et al. The importance of maintaining high hemoglobin levels during radiation treatment of carcinoma of the cervix. Presented at the 30th Annual meeting of the Society for Gynecological Oncology in San Francisco, March, 1999.